Pentax Bronchofiberscope FB-19E
by Pentax Precision Instrument Corp.
510(k) K822844
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK822844 | Date26 Oct 1982 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- EOQ
- Device Class
- Class II
- Regulation
- 21 CFR Part 874.4680
- Advisory Committee
- Ear, Nose, Throat
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Pentax Bronchofiberscope FB-19E is a flexible fiberscope designed for bronchoscopic examination of the airways. It provides visual access to the trachea, bronchi, and surrounding lung tissue, enabling diagnostic and therapeutic interventions in respiratory medicine.
This device is supplied as a reusable medical instrument and is intended for use in clinical settings such as hospitals and outpatient care facilities. It requires proper cleaning, disinfection, and maintenance per manufacturer guidelines, with no specific sterility claims noted. The FB-19E is regulated under FDA 510(k) clearance (K822844) and falls under the Ear, Nose, and Throat advisory committee classification.
Other devices from Pentax Precision Instrument Corp.
Questions
AI-generated answers, 19 Sep 2026
Is the Pentax Bronchofiberscope FB-19E designed for single-use or can it be reused in clinical settings?
The Pentax Bronchofiberscope FB-19E is explicitly supplied as a reusable medical instrument. It requires proper cleaning, disinfection, and maintenance per the manufacturer’s guidelines to ensure safe, repeated use in clinical settings like hospitals and outpatient facilities. Unlike single-use devices, it must be processed between patients to prevent cross-contamination.
What types of procedures is this device intended to support in respiratory medicine?
The FB-19E is a flexible fiberscope designed for bronchoscopic examination, allowing visual access to the trachea, bronchi, and surrounding lung tissue. This enables both diagnostic evaluations (e.g., biopsy sampling, cytology) and therapeutic interventions (e.g., lesion removal, airway clearance) in respiratory care. Its flexibility aids navigation through complex airway anatomy.
How should the FB-19E be stored to maintain its performance and longevity?
Since the FB-19E is reusable, storage must follow the manufacturer’s instructions to preserve its condition. Typically, this involves drying thoroughly after cleaning/disinfection, storing in a clean, dry environment (e.g., a protective case), and avoiding exposure to extreme temperatures or humidity. Proper maintenance extends the device’s lifespan and ensures reliable performance during procedures.
What distinguishes the regulatory pathway for this device, and how does it relate to its intended use?
The FB-19E was cleared via the FDA 510(k) process (traditional pathway, K822844) and classified under the Ear, Nose, and Throat (ENT) advisory committee. This classification reflects its primary use in airway examinations, aligning with ENT-related diagnostic/therapeutic procedures. The ‘substantially equivalent’ decision indicates it meets FDA standards for safety and effectiveness compared to predicate devices, though it does not imply sterility claims.